Optimized geometric design of a cell processing cassette
AssigneeTrenchant BioSystems, Inc.
InventorsPhilip H. Coelho, Paul Getchel, Jonathan Ellis
Life of this patent
Estimating the term…
Loading patent…
AssigneeTrenchant BioSystems, Inc.
InventorsPhilip H. Coelho, Paul Getchel, Jonathan Ellis
Estimating the term…
The disclosed invention presents the AutoCell Platform (ACP), an advanced, fully automated, and functionally closed system designed to revolutionize the manufacturing of gene-modified cell therapies. This innovative platform integrates automation, closed-loop processing, and novel technologies to address the inefficiencies and high costs of conventional methods. Key features include automated spinoculation for enhanced genetic modification efficiency, microbubble-assisted cell selection for precise cell isolation, and modular design for scalability across clinical and research settings. By reducing production timelines from 30-40 days to under 3 days and lowering costs by an order of magnitude, the ACP enables point-of-care manufacturing, decentralization, and broader accessibility. Advanced quality control measures and a standardized design ensure regulatory compliance and consistent therapeutic outcomes. The ACP supports diverse applications, from CAR-T therapies to regenerative medicine, representing a transformative leap in precision medicine and the global accessibility of life-saving cell-based therapies.
A cell processing cassette (CPC) comprising:
A CPC for use in a cell processing platform, comprising:
A method for controlling fluid motion within a CPC during tilting, comprising the steps of:
A method for processing cells within a CPC, the method comprising:
A CPC comprising:
Dependencies are inferred from the claim text.